Orthocell Limited (ASX:OCC)
0.7100
-0.0150 (-2.07%)
Sep 11, 2026, 12:37 PM AEST
Orthocell Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Orthocell stock has a consensus rating of "Strong Buy" and an average price target of $1.14. The average 1-year stock price forecast is 60.56% higher than the current stock price, while the lowest is $1.13 (+59.15%) and the highest is $1.15 (+61.97%).
Price Target: $1.14 (+60.56%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Orthocell stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $1.19 → $1.13 | Buy | Maintains | $1.19 → $1.13 | +59.15% | Sep 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1.33 → $1.26 | Buy | Maintains | $1.33 → $1.26 | +77.46% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
19.00M
from 11.41M
Increased by 66.56%
Revenue Next Year
38.00M
from 19.00M
Increased by 100.00%
EPS This Year
-0.04
from -0.05
EPS Next Year
-0.02
from -0.04
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.